Amgen, Synergen Inc., Genentech Inc preclinical data

The companies and their university collaborators reported in Nature that GDNF can spare dopamine neurons in animal models of Parkinson's disease, and appears to salvage motor neurons as well.

An accompanying editorial cautioned that the data should not be overplayed prior to clinical testing, citing as-yet unpublished findings that the factor

Read the full 515 word article

How to gain access

Continue reading with a
two-week free trial.